Suppr超能文献

澳大利亚北领地的土著儿童和日托中心儿童中 b 型流感嗜血杆菌的携带情况,跨越了疫苗前和疫苗后时代。

Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras.

机构信息

Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.

出版信息

Vaccine. 2011 Apr 5;29(16):3083-8. doi: 10.1016/j.vaccine.2010.09.030. Epub 2010 Sep 25.

Abstract

UNLABELLED

This paper investigates Haemophilus influenzae type b (Hib) carriage in Indigenous children and children attending childcare centres in the Northern Territory of Australia, 1992-2005. More than 10 years after the introduction of the Hib conjugate vaccine, Hib carriage persists in Indigenous children (3.4%, 2003-2005) and children attending childcare centres (0.2%, 2004). This is the first Australian study to examine Hib carriage spanning the pre- and post-vaccination eras. Increasing carriage rates contribute to Hib disease resurgence especially in those with higher disease burdens, such as remote Indigenous Australians, ongoing carriage surveillance provides a sentinel warning system for invasive disease.

BACKGROUND

Following the introduction of H. influenzae type b (Hib) conjugate vaccine to Australia in 1993 as a three dose (2, 4, 12 month) schedule, the incidence of Hib disease decreased dramatically in children, especially in those aged under 5 years. We investigate Hib carriage in Indigenous children and children attending childcare centres from the Northern Territory (NT) of Australia between 1992 and 2005. We report Hib carriage rates in this well vaccinated population, with previously documented high rates of invasive disease.

METHODS

Hib carriage was reviewed in nasopharyngeal or nasal swabs collected between 1992 and 2005; from over 2000 children (61% Indigenous) aged 0-6 years enrolled in 7 otitis media or carriage surveillance studies in the NT.

RESULTS

More than 10 years after the introduction of the Hib conjugate vaccine, Hib carriage persists at low levels, but at a higher rate in Indigenous children (3.4%, 2003-2005) than children attending childcare centres (0.2%, 2004), in the NT of Australia.

CONCLUSIONS

This is the first Australian study to examine Hib carriage spanning the pre- and post-vaccination eras. Ongoing carriage surveillance provides a sentinel warning system for invasive disease. This notifies public health professionals of potential invasive disease, creating early warning systems for intervention if Australian Indigenous children or children attending childcare centres are to follow current international trends associated with high rates of carriage preceding invasive disease-despite high vaccination rates. Internationally there is growing concern that increasing carriage rates are the driving force behind Hib disease resurgence especially in those with higher disease burdens, such as remote Indigenous Australians. Changes to the vaccination schedule from PRP-OMPC (PedvaxHIB(®)), to PRP-T (2, 4, 6, 12 months) from January 2010-may affect carriage and in time, invasive disease rates. This work is important for national and International comparisons as well as feeding back information to vaccine policy makers of the Hib carriage environment throughout this period.

摘要

未加说明

本研究旨在调查 1992-2005 年澳大利亚北部地区土著儿童和日托中心儿童中乙型流感嗜血杆菌(Hib)的携带情况。在 Hib 结合疫苗问世 10 多年后,土著儿童(2003-2005 年为 3.4%)和日托中心儿童(2004 年为 0.2%)中仍存在 Hib 携带。这是澳大利亚第一项考察 Hib 携带情况的研究,横跨疫苗接种前和后两个时期。携带率的上升导致 Hib 病的再次出现,尤其是在疾病负担较高的人群中,如偏远地区的土著澳大利亚人,持续的携带监测为侵袭性疾病提供了预警系统。

背景

1993 年,Hib 结合疫苗在澳大利亚作为三针(2、4、12 个月)方案推出后,Hib 疾病的发病率在儿童中,尤其是 5 岁以下儿童中大幅下降。我们调查了澳大利亚北部地区(NT)1992 年至 2005 年期间土著儿童和日托中心儿童的 Hib 携带情况。我们报告了在这个接种疫苗良好的人群中 Hib 的携带率,该人群之前有记录表明存在高侵袭性疾病发病率。

方法

对 1992 年至 2005 年间收集的鼻咽或鼻腔拭子进行 Hib 携带情况的回顾性分析;来自于在 NT 参加 7 项中耳炎或携带监测研究的 2000 多名(61%为土著人)0-6 岁儿童。

结果

在 Hib 结合疫苗推出 10 多年后,土著儿童(2003-2005 年为 3.4%)的 Hib 携带率仍处于低水平,但高于日托中心儿童(2004 年为 0.2%),这在澳大利亚 NT 地区仍持续存在。

结论

这是澳大利亚第一项考察 Hib 携带情况的研究,横跨疫苗接种前和后两个时期。持续的携带监测为侵袭性疾病提供了一个预警系统。这为澳大利亚土著儿童或日托中心儿童的潜在侵袭性疾病提供了公共卫生专业人员的早期预警,如果他们要遵循当前国际上与侵袭性疾病相关的高携带率趋势,这可能会导致侵袭性疾病,尽管接种率很高。国际上越来越担心,携带率的上升是 Hib 病再次出现的主要原因,尤其是在疾病负担较高的人群中,如偏远地区的土著澳大利亚人。从 2010 年 1 月开始,PRP-OMPC(PedvaxHIB(®))疫苗改为 PRP-T(2、4、6、12 个月),接种方案的改变可能会影响携带率,并在一段时间后影响侵袭性疾病的发生率。这对于国家和国际比较以及向 Hib 携带环境的疫苗政策制定者反馈信息都很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验